Cover Image

Paricalcitol versus Calcitriol + Cinacalcet for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease in China: A Cost-Effectiveness Analysis

Background: Chronic Kidney Disease (CKD) is a global chronic disease with increasing prevalence in recent years, particularly CKD accompanied by Secondary Hyperparathyroidism (SHPT) leads to reduced quality of life, increased mortality, a considerable economic burden for patients and society. The ai...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zhuolin Zhang (Author), Lele Cai (Author), Hong Wu (Author), Xinglu Xu (Author), Wenqing Fang (Author), Xuan He (Author), Xiao Wang (Author), Xin Li (Author)
Format:	Book
Published:	Frontiers Media S.A., 2021-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparison between paricalcitol versus cinacalcet therapy in the management of secondary hyperparathyroidism among prevalent hemodialysis patients
by: Maha A. Behairy, et al.
Published: (2022)

Paricalcitol and Calcitriol Prevent Progression of Chronic Kidney Disease in Uremic Rats
by: Zehra Narlı Özdemir, et al.
Published: (2022)

Management of pre-renal transplant secondary hyperparathyroidism: parathyroidectomy versus cinacalcet
by: Muhammed Ahmed Elhadedy, et al.
Published: (2023)

Cinacalcet versus Parathyroidectomy in the Treatment of Secondary Hyperparathyroidism Post Renal Transplantation
by: Soliman Amin R., et al.
Published: (2016)

Pharmacogenetic analysis of cinacalcet response in secondary hyperparathyroidism patients
by: Jeong S, et al.
Published: (2016)

Cinacalcet in treatment of the secondary hyperparathyroidism relapse in patients on dialysis
by: Olga Vetchinnikova, et al.
Published: (2012)

THE CARDIOVASCULAR EFFECTS OF CINACALCET IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM
by: Sungjin Chung, et al.
Published: (2012)

A comparative study on the effect of calcitriol and cinacalcet on hyperparathyroidism in hemodialysis patients; a double-blinded randomized clinical trial
by: Saeed Mardani, et al.
Published: (2022)

Mechanism of calcitriol regulating parathyroid cells in secondary hyperparathyroidism
by: Zeli Xiang, et al.
Published: (2022)

PHARMACOECONOMIC EVALUATION OF TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS ON DIALYSIS WITH CINACALCET
by: R. I. Yagudina, et al.
Published: (2015)

Long-term effectiveness of cinacalcet in non-dialysis patients with chronic kidney disease and secondary hyperparathyroidism
by: Ariadna Pérez-Ricart, et al.
Published: (2019)

Parathyroidectomy versus cinacalcet in the treatment of tertiary hyperparathyroidism after kidney transplantation: a retrospective study
by: Suyun Jung, et al.
Published: (2022)

Cinacalcet adherence in dialysis patients with secondary hyperparathyroidism in Lombardy Region: clinical implications and costs
by: Alessandro Roggeri, et al.
Published: (2020)

Successful Treatment of Severe Atopic Dermatitis with Calcitriol and Paricalcitol in an 8-Year-Old Girl
by: Christina Bothou, et al.
Published: (2018)

Cinacalcet-Associated Resolution of Primary Hyperparathyroidism in a Patient With Normal Kidney Function
by: Son Nguyen DO, PharmD, et al.
Published: (2020)

Cost-effectiveness analysis of cinacalcet versus vitamin D analogs in secondary hyperparathyroidism in end-stage renal disease patients on dialysis (Protocol)
by: Nilofar Sharahi, et al.
Published: (2017)

Effect of vitamin D analogues calcitriol and paricalcitol in a rat model of puromycin aminonucleoside-induced nephrotic syndrome
by: Hamdi Metin, et al.
Published: (2022)

Diameter of Parathyroid Glands Measured by Computed Tomography as a Predictive Indicator for Response to Cinacalcet in Dialysis Patients with Secondary Hyperparathyroidism
by: Yu Ah Hong, et al.
Published: (2015)

Changes of Serum Total and Free Testosterone Concentrations in Male Chronic Hemodialysis Patients with Secondary Hyperparathyroidism in Response to Cinacalcet Treatment
by: Piotr Kuczera, et al.
Published: (2016)

Off-label use of cinacalcet in pediatric primary hyperparathyroidism: A French multicenter experience
by: Julie Bernardor, et al.
Published: (2022)

Economic Value of Fosaprepitant-Containing Regimen in the Prevention of Chemotherapy-Induced Nausea and Vomiting in China: Cost-Effectiveness and Budget Impact Analysis
by: Xinglu Xu, et al.
Published: (2022)

Evaluating the Price, Availability, and Affordability of Essential Medicines in Primary Healthcare Institutions: A Mixed Longitudinal and Cross-Sectional Study in Jiangsu, China
by: Xiao Wang, et al.
Published: (2022)

Paricalcitol prevents MAPK pathway activation and inflammation in adriamycin-induced kidney injury in rats
by: Amanda Lima Deluque, et al.
Published: (2024)

Calcitriol levels and the stage of chronic kidney disease in children
by: Diska Yulia Trisiana, et al.
Published: (2022)

Integrated Synthesis of Calcitriol and 26,27-Hexadeutero Calcitriol
by: Fei Tang, et al.
Published: (2024)

Laboratory criteria for the persistence of secondary hyperparathyroidism in patients with chronic kidney disease
by: M. Urina, et al.
Published: (2020)

Efficacy and safety of paricalcitol in patients undergoing hemodialysis: a meta-analysis
by: Liu Y, et al.
Published: (2019)

Limited usefulness of calcimimetics for secondary hyperparathyroidism in non-dialysis chronic kidney disease
by: Fizza Abbas, et al.
Published: (2019)

Impact of the National Health Insurance Coverage Policy on the Utilisation and Accessibility of Innovative Anti-cancer Medicines in China: An Interrupted Time-Series Study
by: Wenqing Fang, et al.
Published: (2021)

Comparative Effectiveness of MRI, 4D-CT and Ultrasonography in Patients with Secondary Hyperparathyroidism
by: Mi J, et al.
Published: (2023)

Evaluation of Therapies for Secondary Hyperparathyroidism Associated with Vitamin D Insufficiency in Chronic Kidney Disease
by: Stephen A. Strugnell, et al.
Published: (2023)

Parathyroidectomy Reduces Intradialytic Hypotension in Hemodialysis Patients with Secondary Hyperparathyroidism
by: Chia-Jen Shih, et al.
Published: (2013)

Secondary Prevention of Diabetes Type 1 with Oral Calcitriol and Analogs, the PRECAL Study
by: Dimitrios T. Papadimitriou, et al.
Published: (2023)

Cost-effectiveness of preimplantation genetic testing for aneuploidy for women with subfertility in China: an economic evaluation using evidence from the CESE-PGS trial
by: Xuan He, et al.
Published: (2023)

Treatment of secondary hyperparathyroidism: the clinical utility of etelcalcetide
by: Cozzolino M, et al.
Published: (2017)

Long-term Outcomes of Parathyroidectomy in Kidney Transplant Recipients with Persistent Hyperparathyroidism
by: Po-Yu Tseng, et al.
Published: (2015)

Peroxygenase-Catalyzed Selective Synthesis of Calcitriol Starting from Alfacalcidol
by: Yuanying Li, et al.
Published: (2022)

Cardiac and Renal Effects of Atrasentan in Combination with Enalapril and Paricalcitol in Uremic Rats
by: Cynthia Ritter, et al.
Published: (2014)

Association Between Secondary Hyperparathyroidism and Body Composition in Pediatric Patients With Moderate and Advanced Chronic Kidney Disease
by: Vasiliki Karava, et al.
Published: (2021)

Oral manifestations of secondary hyperparathyroidism: A case report
by: Sunita P Kakade, et al.
Published: (2015)